Clinical Trials Logo
  1. Home
  2. Common Wart
  3. NCT05896215

OM202JP Clinical Study of KNP2002

Common Wart Clinical Trial

Official title:
A Phase II Clinical Study of KNP2002 Ointment in Patients With Common Warts (OM202JA)

Clinical Trial Summary

The goal of this clinical trial is to evaluate safety and efficacy of KNP2002 in patients with common warts aged 15 to 50 years old.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05896215
Study type Interventional
Source KinoPharma Inc.
Contact
Status Active, not recruiting
Phase Phase 2
Start date June 12, 2023
Completion date May 31, 2024
View Details
See also
  Status Clinical Trial Phase
Suspended NCT01796795 - Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients Phase 2
Completed NCT03687372 - Study of A-101 Topical Solution for the Treatment of Common Warts Phase 3
Completed NCT03691831 - A Study of A-101 Topical Solution for the Treatment of Common Warts Phase 3
Completed NCT00328991 - Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts N/A
Completed NCT05115669 - Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts N/A
Completed NCT03487549 - Cantharidin and Occlusion in Verruca Epithelium Phase 2
Not yet recruiting NCT04288817 - Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts Phase 3
Completed NCT03278028 - A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts Phase 2
Completed NCT03812510 - Safety Study of A-101 Topical Solution for the Treatment of Common Warts Phase 3
Recruiting NCT05799157 - Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts Phase 2
Recruiting NCT06214559 - Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts. N/A
Recruiting NCT03977753 - Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts Phase 4
Completed NCT03210337 - A Phase2 of A-101 Topical Solution in Subjects With Common Warts Phase 2
Completed NCT03183765 - Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts Phase 4